Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
2,447.15
2,312.86
2,043.38
1,856.32
1,825.55
1,726.84
1,556.92
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,447.15
2,312.86
2,043.38
1,856.32
1,825.55
1,726.84
1,556.92
Raw Material Cost
1,408.66
1,238.08
1,091.10
978.69
933.44
869.30
792.71
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
511.81
490.73
481.42
423.91
436.70
407.61
379.48
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
68.87
69.99
56.83
40.72
42.11
40.76
40.50
Selling and Distribution Expenses
453.12
546.24
424.59
343.20
353.26
345.68
314.23
Other Expenses
-47.03
-44.09
-42.13
-36.43
-37.51
-35.27
-33.52
Total Expenditure (Excl Depreciation)
1,972.12
1,904.18
1,632.60
1,422.23
1,390.41
1,310.61
1,191.69
Operating Profit (PBDIT) excl Other Income
475
408.7
410.79999999999995
434.09999999999997
435.09999999999997
416.2
365.20000000000005
Other Income
-11.74
-0.80
-7.31
-26.18
-16.38
-2.35
6.75
Operating Profit (PBDIT)
617.46
547.85
557.73
529.34
524.04
467.18
407.23
Interest
68.87
69.99
56.83
40.72
42.11
40.76
40.50
Exceptional Items
-39.13
-98.15
-157.50
27.63
58.49
50.17
-65.25
Gross Profit (PBDT)
1,038.49
1,074.77
952.28
877.62
892.11
857.54
764.21
Depreciation
154.17
153.65
154.25
121.43
105.28
91.71
81.75
Profit Before Tax
355.29
226.06
189.16
394.82
435.14
384.87
219.74
Tax
72.78
71.60
34.10
90.16
99.82
3.14
6.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
280.95
152.85
152.62
306.11
336.10
380.96
211.49
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
280.95
152.85
152.62
306.11
336.10
380.96
211.49
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
2.35
1.61
2.44
-0.73
-0.78
0.78
2.25
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
283.30
154.46
155.06
305.39
335.32
381.74
213.74
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
1,844.46
1,724.19
1,774.88
1,811.07
1,561.87
1,598.04
1,323.02
Earnings per share (EPS)
1.26
0.69
0.68
1.31
1.41
1.57
0.87
Diluted Earnings per share
1.26
0.69
0.68
1.31
1.41
1.57
0.87
Operating Profit Margin (Excl OI)
19.41%
17.08%
20.1%
23.38%
23.84%
21.88%
20.47%
Gross Profit Margin
20.82%
16.42%
16.81%
27.81%
29.6%
27.6%
19.36%
PAT Margin
11.48%
6.61%
7.47%
16.49%
18.41%
22.06%
13.58%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 5.81% vs 13.19% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is 83.37% vs -0.39% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 14.69% vs -2.90% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is -1.57% vs 23.24% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has improved from Dec 2023
Compare Annual Results Of Hikma Pharmaceuticals Plc With
Figures in Million
Consolidate Annual Results
Change(GBP)
Change(%)
Net Sales
2,447.15
32,667.00
-30,219.85
-92.51%
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,447.15
32,667.00
-30,219.85
-92.51%
Raw Material Cost
1,408.66
9,323.00
-7,914.34
-84.89%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
511.81
8,398.00
-7,886.19
-93.91%
Power Cost
0
0
0.00
Manufacturing Expenses
68.87
667.00
-598.13
-89.67%
Selling and Distribution Expenses
453.12
8,926.00
-8,472.88
-94.92%
Other Expenses
-47.03
-286.50
239.47
83.58%
Total Expenditure (Excl Depreciation)
1,972.12
24,449.00
-22,476.88
-91.93%
Operating Profit (PBDIT) excl Other Income
475.03
8,218.00
-7,742.97
-94.22%
Other Income
-11.74
1,450.00
-1,461.74
-100.81%
Operating Profit (PBDIT)
617.46
11,982.00
-11,364.54
-94.85%
Interest
68.87
667.00
-598.13
-89.67%
Exceptional Items
-39.13
-1,601.00
1,561.87
97.56%
Gross Profit (PBDT)
1,038.49
23,344.00
-22,305.51
-95.55%
Depreciation
154.17
2,314.00
-2,159.83
-93.34%
Profit Before Tax
355.29
7,400.00
-7,044.71
-95.20%
Tax
72.78
1,112.00
-1,039.22
-93.46%
Provisions and contingencies
0
0
0.00
Profit After Tax
280.95
5,716.00
-5,435.05
-95.08%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
280.95
5,716.00
-5,435.05
-95.08%
Share in Profit of Associates
0
0
0.00
Minority Interest
2.35
573.00
-570.65
-99.59%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
283.30
6,289.00
-6,005.70
-95.50%
Equity Capital
0
0
0.00
Face Value
0.00
0.31
0.00
Reserves
1,844.46
16,377.00
-14,532.54
-88.74%
Earnings per share (EPS)
1.26
1.39
-0.13
-9.35%
Diluted Earnings per share
1.26
1.39
-0.13
-9.35%
Operating Profit Margin (Excl OI)
19.41%
25.16%
0.00
-5.75%
Gross Profit Margin
20.82%
29.74%
0.00
-8.92%
PAT Margin
11.48%
17.50%
0.00
-6.02%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 244.72 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 5.81% vs 13.19% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 28.33 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 83.37% vs -0.39% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 62.92 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 14.69% vs -2.90% in Dec 2023
Annual - Interest
Interest 6.89 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -1.57% vs 23.24% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.41%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has improved from Dec 2023
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
